EUVIMEDEUVIMED entdecken
Crossref

Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors

Asael Roichman, Qianying Zuo, Sunghoon Hwang, Wenyun Lu, Ricardo A Cordova, Michael R MacArthur, Jacob A Boyer, Sarah J Mitchell, Jesse Powers, Sophia A Koval, Craig J Hunter, Jamie Rijmers und 14 weitere

Cell · 2025-05 · 188 (11) · 3065-3080.e21

DOI: 10.1016/j.cell.2025.04.041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2025-05. Verfasst von Asael Roichman und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Princeton University, Princeton, NJ 08544, USA; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Prince…. Hauptthemen laut MEDLINE: Phytochemicals, Phosphoinositide-3 Kinase Inhibitors, Gastrointestinal Microbiome, Antineoplastic Agents. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylinositol 3-kinase (PI3K) signaling is both the effector pathway of insulin and among the most frequently activated pathways in human cancer. In murine cancer models, the efficacy of PI3K inhibitors is dramatically enhanced by a ketogenic diet, with a proposed mechanism involving dietary suppression of insulin. Here, we confirm profound diet-PI3K anticancer synergy but show that it is, surprisingly, unrelated to diet macronutrient composition. Instead, the diet-PI3K interaction involves microbiome metabolism of ingested phytochemicals. Specifically, murine ketogenic diet lacks the complex spectrum of phytochemicals found in standard chow, including the soy phytochemicals soyasaponins. We find that soyasaponins are converted by the microbiome into inducers of hepatic cytochrome P450 enzymes, and thereby lower PI3K inhibitor blood levels and anticancer activity. A high-carbohydrate, low-phytochemical diet synergizes with PI3K inhibition to treat cancer in mice, as do antibiotics that curtail the gut microbiome. Thus, diet impacts anticancer drug activity through phytochemical-microbiome-liver interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytochemicalsPhosphoinositide-3 Kinase InhibitorsGastrointestinal MicrobiomeAntineoplastic AgentsNeoplasmsMicrobiotaAnimalsMiceHumansDiet, KetogenicMice, Inbred C57BLPhosphatidylinositol 3-KinasesLiverSaponinsMaleCell Line, Tumor

Stichwörter der Autor:innen

PI3Kibreast cancercytochrome P450diet and cancer treatmentgut-liver axismicrobiome metabolitespancreatic cancerpharmacokineticsphytochemicalssoyasaponins

Substanzen

PhytochemicalsPhosphoinositide-3 Kinase InhibitorsAntineoplastic AgentsPhosphatidylinositol 3-KinasesSaponins

Autor:innen und Institutionen

  • Department of Chemistry, Princeton University, Princeton, NJ 08544, USA; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA; Ludwig Institute for Cancer Research, Princeton Branch,…
  • Ludwig Institute for Cancer Research, Princeton Branch, Princeton, NJ, USA; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Ludwig Institute for Cancer Research, Princeton Branch, Princeton, NJ, USA.
  • Rutgers Cancer Institute, New Brunswick, NJ, USA.
  • Department of Chemistry, Princeton University, Princeton, NJ 08544, USA; Lewis-Sigler Institute of Integrative Genomics, Princeton University, Princeton, NJ, USA.

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • National Institutes of Health
  • Damon Runyon Cancer Research Foundation
  • Ludwig Institute for Cancer Research
  • Foundation for the National Institutes of Health

Zitieren

APA

Roichman, A., Zuo, Q., Hwang, S., Lu, W., Cordova, R. A., MacArthur, M. R., Boyer, J. A., Mitchell, S. J., Powers, J., Koval, S. A., Hunter, C. J., Rijmers, J., Ryseck, R. P., AbuSalim, J. E., Chatterjee, S., Lee, W. D., Xu, X., Xing, X., Chen, Z., …, & Rabinowitz, J. D. (2025). Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors. Cell, 188(11), 3065-3080.e21. https://doi.org/10.1016/j.cell.2025.04.041

Vancouver

Roichman A, Zuo Q, Hwang S, Lu W, Cordova RA, MacArthur MR, et al. Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors. Cell. 2025;188(11):3065-3080.e21. doi:10.1016/j.cell.2025.04.041

BibTeX
@article{Roichman2025,
  author = {Roichman, Asael and Zuo, Qianying and Hwang, Sunghoon and Lu, Wenyun and Cordova, Ricardo A and MacArthur, Michael R and Boyer, Jacob A and Mitchell, Sarah J and Powers, Jesse and Koval, Sophia A and Hunter, Craig J and Rijmers, Jamie and Ryseck, Rolf-Peter and AbuSalim, Jenna E and Chatterjee, Seema and Lee, Won Dong and Xu, Xincheng and Xing, Xi and Chen, Zihong and Zeng, Xianfeng and Marwaha, Siddharth and McBride, Matthew J and Guo, Jessie Y and Kang, Yibin and Donia, Mohamed S and Rabinowitz, Joshua D},
  title = {Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3K inhibitors},
  journal = {Cell},
  year = {2025},
  volume = {188},
  number = {11},
  pages = {3065--3080.e21},
  doi = {10.1016/j.cell.2025.04.041}
}
Kostenlos starten →